| Oct 29 |
Monte Rosa Therapeutics Shares Skyrocket After $2.1 Billion Deal with Novartis
|
| Oct 28 |
Monte Rosa Almost Doubles — Up 94% — On A Massive Deal With Novartis
|
| Oct 28 |
Monte Rosa: Novartis Deal Bolsters MGD Platform With Flush Of Cash
|
| Oct 28 |
This Biotech Stock Has Doubled Its Value Today—Here's Why
|
| Oct 28 |
PROCEPT BioRobotics Posts Strong Q3 Earnings, Joins Monte Rosa Therapeutics, EyePoint Pharmaceuticals And Other Big Stocks Moving Higher On Monday
|
| Oct 28 |
Novartis to pay Monte Rosa $150 million upfront to develop a new class of drugs
|
| Oct 28 |
Why Is Monte Rosa Therapeutics Stock Surging On Monday?
|
| Oct 28 |
Monte Rosa jumps on $150M license deal with Novartis
|
| Oct 28 |
Monte Rosa Therapeutics Enters Global License Deal With Novartis; Shares Jump Pre-Bell
|
| Oct 28 |
Monte Rosa joins with Novartis in ‘molecular glue’ drug deal
|
